Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathyKrzysztof Kiryluk, Dmitry Samsonov, Heather N. Reich et al.|Nature Genetics|2023Cited by 187
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular DiseaseLaura Mariani, Elisa Delbarba, Andrew S. Bomback et al.|American Journal of Kidney Diseases|2018Cited by 139
Health-related quality of life in glomerular diseasePietro A. Canetta, S. Ali Husain, Jonathan P. Troost et al.|Kidney International|2019Cited by 59
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy StudyChia-shi Wang, Agnieszka Perkowska‐Ptasińska, Dorey A. Glenn et al.|American Journal of Kidney Diseases|2023Cited by 13
GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathyKrzysztof Kiryluk, Dmitry Samsonov, Elena Sánchez et al.|medRxiv|2021Cited by 5